News Releases

BRIDGEWATER, N.J., Sept. 5, 2017 /PRNewswire/ -- Salix Pharmaceuticals today announced it will be presenting data from four abstracts at this year's PAINWeek, the largest national conference on pain for frontline practitioners being held in Las Vegas, September 5-9, 2017. Additional Salix activities at this 11th annual meeting include two product theatres and booth activities (#211).

Below is a list of the posters to be presented by Salix Pharmaceuticals at PAINWeek 2017:

Poster Presentations

• POSTER #85: Analgesia Maintenance with Oral Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain in a Phase 3, Randomized, Controlled Trial
• POSTER #84: Treatment-Emergent Adverse Events Related to Cardiac Safety in a Phase 3, Randomized, Controlled Trial of Oral Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain
• POSTER #83: Safety of Oral Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: Results from a Phase 3, Randomized, Controlled Trial
• POSTER #113: Characterization of Abdominal Pain Response in Patients with Diarrhea-predominant Irritable Bowel Syndrome Treated with Rifaximin

Product Theatres

Title:          Salix Pharmaceuticals Invites You to a Talk on Opioid-Induced Constipation

Date:         Tuesday, September 5, 2017                                         Friday, September 8, 2017

Time:         3:40-4:30 PM Pacific Time                                             8:00-9:00 AM Pacific Time

Location:   The Cosmopolitan Hotel                                                 The Cosmopolitan Hotel
                  Castellana Ballroom, Level 3                                          Brera Ballroom, Level 3      

Speaker:    Jeffrey Gudin, MD                                                          Gerald M. Sacks, MD
                  Director, Pain Management and Palliative Care            Director of Management    
                  Englewood Hospital and Medical Center                       Pain Institute of Santa Monica  

To receive more information about these posters and product theatres and/or coordinate an interview with a speaker, please contact Kristin Capone, 973-588-2108 or kcapone@coynepr.com.

MTB.0116.USA.17

SOURCE Salix Pharmaceuticals, Ltd.